Inhibrx Biosciences, Inc. · NASDAQ:INBX
Viking Global Investors LP reported a 9.99% stake in Inhibrx Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Viking Global Investors LP reported a 9.99% stake in Inhibrx Biosciences, Inc., 1,454,608 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,454,608
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 12 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 9.99% | 1,454,608 |
| Viking Global Opportunities Parent GP LLC | 9.99% | 1,454,608 |
| Viking Global Opportunities GP LLC | 9.30% | 1,351,744 |
| Viking Global Opportunities Portfolio GP LLC | 8.80% | 1,284,726 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 8.80% | 1,284,726 |
| KAVRA 104 LLC | 0.50% | 67,018 |
| Viking Global Opportunities Drawdown GP LLC | 0.70% | 102,864 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 0.70% | 102,864 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 0.70% | 102,864 |
| HALVORSEN OLE ANDREAS | 9.99% | 1,454,608 |
| Ott David C. | 9.99% | 1,454,608 |
| Shabet Rose Sharon | 9.99% | 1,454,608 |
Source
Related
- Inhibrx Biosciences, Inc.
- Viking Global Investors LP
- Inhibrx Biosciences, Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · Aug 14, 2026
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Form 4 · Lappe Mark · Oct 14, 2026
- Form 4 · Lappe Mark · Sep 28, 2026
- Form 4 · Kayyem Jon Faiz · Sep 23, 2026
- Form 4 · Kayyem Jon Faiz · Sep 17, 2026
- Form 4 · Manhard Kimberly · Sep 15, 2026